[go: up one dir, main page]

WO2010063030A3 - Dermal application of vasoconstrictors - Google Patents

Dermal application of vasoconstrictors Download PDF

Info

Publication number
WO2010063030A3
WO2010063030A3 PCT/US2009/066124 US2009066124W WO2010063030A3 WO 2010063030 A3 WO2010063030 A3 WO 2010063030A3 US 2009066124 W US2009066124 W US 2009066124W WO 2010063030 A3 WO2010063030 A3 WO 2010063030A3
Authority
WO
WIPO (PCT)
Prior art keywords
vasoconstrictors
dermal application
disclosed
vasocontrictor
onset
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2009/066124
Other languages
French (fr)
Other versions
WO2010063030A2 (en
Inventor
Oron Zachar
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
FEIGELSON DANIEL
Original Assignee
FEIGELSON DANIEL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/IL2009/000652 external-priority patent/WO2010001391A1/en
Application filed by FEIGELSON DANIEL filed Critical FEIGELSON DANIEL
Priority to CN2009801558027A priority Critical patent/CN102300566A/en
Priority to EP09829849A priority patent/EP2376073A2/en
Publication of WO2010063030A2 publication Critical patent/WO2010063030A2/en
Priority to US12/982,117 priority patent/US20110144209A1/en
Publication of WO2010063030A3 publication Critical patent/WO2010063030A3/en
Priority to US13/118,563 priority patent/US20120095104A1/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

There is disclosed the topical dermal use of vasocontrictor substances for regulating body temperature to treat, prevent or delay the onset of anesthetic induced hypothermia. Kits containing appropriate materials and instructions, and other embodiments, are also disclosed.
PCT/US2009/066124 2008-06-30 2009-11-30 Dermal application of vasoconstrictors Ceased WO2010063030A2 (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
CN2009801558027A CN102300566A (en) 2008-11-30 2009-11-30 Skin application of vasoconstrictors
EP09829849A EP2376073A2 (en) 2008-11-30 2009-11-30 Dermal application of vasoconstrictors
US12/982,117 US20110144209A1 (en) 2008-06-30 2010-12-30 Use of vasoconstrictors
US13/118,563 US20120095104A1 (en) 2008-11-30 2011-05-30 Use of vasoconstrictors

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US11861208P 2008-11-30 2008-11-30
US61/118,612 2008-11-30
PCT/IL2009/000652 WO2010001391A1 (en) 2008-06-30 2009-06-30 Dermal application of vasoconstrictors
ILPCT/IL2009/000652 2009-06-30

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL2009/000652 Continuation-In-Part WO2010001391A1 (en) 2008-06-30 2009-06-30 Dermal application of vasoconstrictors

Related Child Applications (2)

Application Number Title Priority Date Filing Date
PCT/IL2009/000652 Continuation-In-Part WO2010001391A1 (en) 2008-06-30 2009-06-30 Dermal application of vasoconstrictors
US12/982,117 Continuation-In-Part US20110144209A1 (en) 2008-06-30 2010-12-30 Use of vasoconstrictors

Publications (2)

Publication Number Publication Date
WO2010063030A2 WO2010063030A2 (en) 2010-06-03
WO2010063030A3 true WO2010063030A3 (en) 2011-04-21

Family

ID=42226391

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2009/066124 Ceased WO2010063030A2 (en) 2008-06-30 2009-11-30 Dermal application of vasoconstrictors

Country Status (3)

Country Link
EP (1) EP2376073A2 (en)
CN (1) CN102300566A (en)
WO (1) WO2010063030A2 (en)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10478505B2 (en) 2011-09-23 2019-11-19 The Regents Of The University Of California Edible oils to enhance delivery of orally administered steroids
RU2019104004A (en) 2012-01-23 2019-03-07 Сейдж Терапьютикс, Инк. MEDICINAL FORMS OF NEUROACTIVE STEROIDS AND METHODS OF TREATING CNS DISORDERS
KR102305359B1 (en) 2012-08-21 2021-09-24 세이지 테라퓨틱스, 인크. Methods of treating epilepsy or status epilepticus
JP2016501876A (en) 2012-11-30 2016-01-21 ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア Anticonvulsant activity of steroids
ES2847936T3 (en) 2013-10-07 2021-08-04 Teikoku Pharma Usa Inc Methods and compositions for the transdermal delivery of a non-sedating amount of dexmedetomidine
KR101827980B1 (en) 2013-10-07 2018-02-13 테이코쿠 팔마 유에스에이, 인코포레이티드 Dexmedetomidine transdermal delivery devices and methods for using the same
ES2856189T3 (en) 2013-10-07 2021-09-27 Teikoku Pharma Usa Inc Methods and compositions for the treatment of attention deficit hyperactivity disorder, anxiety and insomnia using transdermal compositions of dexmedetomidine
JOP20200195A1 (en) 2014-09-08 2017-06-16 Sage Therapeutics Inc Neuroactive steroids and formulations, and their uses
NZ785712A (en) 2016-03-08 2025-03-28 Sage Therapeutics Inc Neuroactive steroids, compositions, and uses thereof
ES2895764T3 (en) * 2016-12-26 2022-02-22 Hisamitsu Pharmaceutical Co microneedle device
CN112351809B (en) 2018-06-26 2023-07-14 久光制药株式会社 Microneedle device and manufacturing method thereof

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
ALFONSI P.: "Postanaesthetic shivering. Epidemiology, pathophysiology, and approaches to prevention and management", MINERVA ANESTESIOLOGICA, vol. 69, no. 5, May 2003 (2003-05-01), pages 438 - 442, XP008141457 *

Also Published As

Publication number Publication date
EP2376073A2 (en) 2011-10-19
WO2010063030A2 (en) 2010-06-03
CN102300566A (en) 2011-12-28

Similar Documents

Publication Publication Date Title
WO2010063030A3 (en) Dermal application of vasoconstrictors
WO2010003935A3 (en) Temperature reducing, healing wound dressing
WO2007090068A3 (en) Cyanoisoquinoline compounds that stabilize hypoxia inducible factor (hif)
HRP20130387T1 (en) Preparation for wound healing and prevention of bandage adhesion to the wound, containing chitosan-glucan
MY169564A (en) Substituted dihydropyrazolones and their use
WO2010068794A3 (en) Hif inhibitors and use thereof
WO2008079245A3 (en) Orally disintegrating solid dosage forms comprising progestin and methods of making and use thereof
WO2007103719A3 (en) MODULATORS OF 11-β HYDROXYL STEROID DEHYDROGENASE TYPE 1, PHARMACEUTICAL COMPOSITIONS THEREOF, AND METHODS OF USING THE SAME
WO2012064667A3 (en) Treatment of addiction and impulse-control disorders using pde7 inhibitors
WO2011085162A3 (en) Topical transdermal dexmedetomidine compositions and methods of use thereof
GT201100118A (en) ARILO COMPOUNDS WITH HETEROCYCLIC SUBSTITUTES AS HIF INHIBITORS
WO2009114810A3 (en) Use of ellagitannins as inhibitors of bacterial quorum sensing
WO2009000954A3 (en) Use of estriol in low doses
WO2010036395A3 (en) Treatment of organophosphate exposure with tetrahydroindolone arylpiperazine compounds
WO2008070859A3 (en) Treatment of skin conditions by dickkopf1 (dkk1)
UY31765A (en) SUBSTITUTED DIHYDROPIRAZOLONAS AND ITS USE
WO2008006226A8 (en) Transdermal formulations of synthetic cannabinoids and nano colloidal silica
MY182983A (en) A skin external composition comprising a salt and sugar as active ingredients for preventing and treating vaginosis and the use thereof
DE502006002304D1 (en) Topical cosmetic formulations for regulating and improving the moisture content of the skin
GB2476202A (en) Novel choline cocrystal of epalrestat
WO2009031099A3 (en) Cosmetic use of microorganisms
AU2007211617A1 (en) Hydrogel
WO2009067856A8 (en) Histone deacetylase inhibitor, composition and use thereof
WO2010011926A3 (en) A novel betaine cocrystal of epalrestat
EP2207555A4 (en) Novel compounds for the treatment or alleviation of edema, and methods for their use

Legal Events

Date Code Title Description
WWE Wipo information: entry into national phase

Ref document number: 200980155802.7

Country of ref document: CN

NENP Non-entry into the national phase

Ref country code: DE

WWE Wipo information: entry into national phase

Ref document number: 2009829849

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 09829849

Country of ref document: EP

Kind code of ref document: A2